Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
103.43
+0.14 (0.14%)
Feb 20, 2026, 4:00 PM EST - Market closed
Exact Sciences Employees
Exact Sciences had 7,200 employees as of December 31, 2025. The number of employees increased by 200 or 2.86% compared to the previous year.
Employees
7,200
Change (1Y)
200
Growth (1Y)
2.86%
Revenue / Employee
$450,971
Profits / Employee
-$28,882
Market Cap
19.74B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7,200 | 200 | 2.86% |
| Dec 31, 2024 | 7,000 | 400 | 6.06% |
| Dec 31, 2023 | 6,600 | 200 | 3.13% |
| Dec 31, 2022 | 6,400 | -100 | -1.54% |
| Dec 31, 2021 | 6,500 | 1,500 | 30.00% |
| Dec 31, 2020 | 5,000 | 890 | 21.65% |
| Dec 31, 2019 | 4,110 | 2,133 | 107.89% |
| Dec 31, 2018 | 1,977 | 709 | 55.91% |
| Dec 31, 2017 | 1,268 | 532 | 72.28% |
| Dec 31, 2016 | 736 | 59 | 8.71% |
| Dec 31, 2015 | 677 | 441 | 186.86% |
| Dec 31, 2014 | 236 | 134 | 131.37% |
| Dec 31, 2013 | 102 | 15 | 17.24% |
| Dec 31, 2012 | 87 | 26 | 42.62% |
| Dec 31, 2011 | 61 | 26 | 74.29% |
| Dec 31, 2010 | 35 | 16 | 84.21% |
| Dec 31, 2009 | 19 | 15 | 375.00% |
| Dec 31, 2008 | 4 | -10 | -71.43% |
| Dec 31, 2007 | 14 | -8 | -36.36% |
| Dec 31, 2006 | 22 | -27 | -55.10% |
| Dec 31, 2005 | 49 | -22 | -30.99% |
| Dec 31, 2004 | 71 | -11 | -13.41% |
| Dec 31, 2003 | 82 | 7 | 9.33% |
| Dec 31, 2002 | 75 | 7 | 10.29% |
| Dec 31, 2001 | 68 | 24 | 54.55% |
| Dec 31, 2000 | 44 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 93,000 |
| Labcorp Holdings | 70,000 |
| Quest Diagnostics | 56,000 |
| Mettler-Toledo International | 18,100 |
| Agilent Technologies | 18,100 |
| Revvity | 11,000 |
| Illumina | 10,080 |
| Waters | 7,600 |
EXAS News
- 1 day ago - Exact Sciences Stockholders Approve Acquisition by Abbott - Business Wire
- 6 days ago - Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells - Seeking Alpha
- 8 days ago - Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results - Business Wire
- 9 days ago - Alger Mid Cap 40 ETF Q4 2025 Portfolio Update - Seeking Alpha
- 9 days ago - Baron Opportunity Fund Q4 2025 Portfolio Activity - Seeking Alpha
- 15 days ago - Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences' '746 Patent - Business Wire
- 18 days ago - Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests - Business Wire
- 18 days ago - Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide - Business Wire